CAMBRIDGE, Mass. & BUDAPEST, Hungary—Biodata, producer of Labguru, a web-based electronic lab notebook with integrated protocols and specimen management systems, and ChemAxon, a provider of chemistry software solutions and consulting services for life-sciences research, announced in late April a collaboration leading to the development of Labguru’s newest feature: chemical structure and reaction support.
Already possessing “a set of deep domain features for biologists, biochemists and more,” Biodata notes, “the integration of ChemAxon’s Marvin JS makes it possible for chemists around the world to add chemical molecules and reaction drawings directly to their experiments, milestones and projects within Labguru.”
Labguru’s CEO, Louis Culot, said in a news release about the deal: “Adding deep support for chemistry is a priority for Biodata in 2015. With our partnership with ChemAxon, we have started the process and look forward to further developments that enhance Labguru for chemists and biochemists—and to help them properly annotate and find experiments and make reaction planning and optimization simpler and more powerful.”
So, why ChemAxon’s Marvin JS?
It also is cross-compatible with ChemDraw and MarvinSketch, Biodata points out. Reportedly, scientists who use these chemical editors can simply copy-paste their chemical reactions into Marvin JS with no problem while preserving the important metadata carried in the background (e.g., reaction mapping).
With offices in Boston, Austin, Tel Aviv and London, BioData—a sister company to Nature Publishing Group—creates digital tools for increasing the productivity of academic and industry laboratories. ChemAxon is a leader in providing cheminformatics software platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. The company is privately owned, with European headquarters in Budapest, U.S. headquarters in Cambridge, Mass., and sales and support offices in Europe, Japan and across North America.